SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Averion International Corp. (OTCBB:AVRO), a clinical research organization (CRO) specializing in oncology, cardiovascular diseases, and medical devices, today announced the appointment of Lawrence R. Hoffman as Chief Financial Officer, effective May 12, 2008. Mr. Hoffman replaces Christopher G. Codeanne, who previously announced his resignation.
